ENGN enGene Holdings Inc
910
$8.79
$1.71
(16.29%)
| Watchers | 910 |
| 52-Wk Low | $6.69 |
| 52-Wk High | $47.17 |
| Market Cap | $203.91M |
| Volume | 127,532.00 |
| 52-Wk High | $47.17 |
| 52-Wk Low | $6.69 |
enGene to Present at the Jefferies Global Healthcare ConferenceBusiness Wire • 3 days ago
enGene Holdings Inc. (Nasdaq: ENGN or enGene or the Company), a clinical-stage genetic medicines company whose non-viral lead program EG-70 is in a pivotal study for BCG-unresponsive non-muscle...
Share to Feed
enGene Holdings Inc. (Nasdaq: ENGN or enGene or the Company), a clinical-stage genetic medicines company whose non-viral lead program EG-70 is in a pivotal study for BCG-unresponsive non-muscle...
enGene to Present Details of its Pivotal Phase 1/2 LEGEND Study of EG-70 in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer with Carcinoma in situ at the American Urology Association 2024 Annual...
/C O R R E C T I O N -- enGene Inc./ /C O R R E C T I O N -- enGene Inc./ PR Newswire BOSTON and MONTREAL, April 9, 2024 In the news release, engender Announces Hiring of Dr. Raja Ruth as Senior Vice...
engender Announces Hiring of Dr. Raja Ruth as Senior Vice President, Urologic Oncology and Clinical Development engender Announces Hiring of Dr. Raja Ruth as Senior Vice President, Urologic Oncology...
enGene Reports First Quarter 2024 Financial Results and Recent Corporate Progress enGene Reports First Quarter 2024 Financial Results and Recent Corporate Progress PR Newswire BOSTON and MONTREAL...
enGene To Present at the Leerink Partners Global Biopharma Conference enGene To Present at the Leerink Partners Global Biopharma Conference PR Newswire BOSTON and MONTREAL, March 5, 2024 BOSTON and...
enGene To Present at the Leerink Partners Global Biopharma Conference enGene To Present at the Leerink Partners Global Biopharma Conference Canada NewsWire BOSTON and MONTREAL, March 5, 2024 BOSTON...
enGene Holdings Inc. (NASDAQ:ENGN Free Report) Equities researchers at Leerink Partnrs issued their Q1 2024 EPS estimates for shares of enGene in a note issued to investors on...
enGene Announces Oversubscribed $200 Million Private Placement Financing enGene Announces Oversubscribed $200 Million Private Placement Financing Canada NewsWire BOSTON and MONTREAL, Feb. 14, 2024...